QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 08:10 UTC · Public disclosure record

KVUETICKER

Kenvue Inc.

BULLISH stock

Congress has disclosed 16 buys and 12 sells of KVUE (Kenvue Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

16
Buy
12
Sell
+4
Net
9
Active politicians

Round-trip watch Still on the books

Members who disclosed buying KVUE and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.

MemberEntry (last buy)Entry priceNowvs entryStatus
Rohit Khanna 2025-12-05 $16.16 $19.31 +19.5% in profit
Alan Armstrong 2026-03-27 $16.92 $19.31 +14.1% in profit

Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).

Price & congressional trades
Buy Sell

Fundamentals · FY2026 Valuation

Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Chemicals. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.

P/E
21.96
≈ in line with Chemicals (median 23.4)
how it's calculated
P/E = price ÷ earnings per share
$19.31 ÷ $0.88 = 21.96
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
3.65
≈ in line with Chemicals (median 3.6)
how it's calculated
P/B = price ÷ book value per share
$19.31 ÷ $5.29 = 3.65
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
13.22
▼ cheaper than Chemicals (median 17.5)
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA
($37.1B + $6.0B net debt) ÷ $3.3B = $43.2B ÷ $3.3B = 13.22
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.

28 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Kevin Hern House SELL ◆ insider convergence Joint · Hern Family Foundation 2026-08-05 0 days 0.0% $1K–$15K
0.1% of NW
60.0 ↗ filing
Gilbert Cisneros House SELL ◆ insider convergence Self · 150 Main Street Trust > Bank of America 2026-07-17 28 days +2.3% $1K–$15K
0.1% of NW
29.4 ↗ filing
Gilbert Cisneros House BUY ◆ insider divergence Self · 150 Main Street Trust > Bank of America 2026-06-16 16 days +7.6% $1K–$15K
0.1% of NW
14.0 ↗ filing
Alan Armstrong Senate BUY ◆ insider divergence Self 2026-03-27 116 days +9.8% $1K–$15K 82.9 ↗ eFD
Kevin Hern House SELL ◆ insider convergence Joint · Hern Family Revocable Trust 2026-03-17 14 days -3.0% $15K–$50K
0.4% of NW
88.6 ↗ filing
Gilbert Cisneros House SELL ◆ insider convergence Self · 150 Main Street Trust > Bank of America 2026-03-13 24 days -1.1% $1K–$15K
0.1% of NW
18.7 ↗ filing
Gilbert Cisneros House BUY ◆ insider convergence · moderate Self · 150 Main Street Trust > Bank of America 2026-02-10 24 days +1.5% $1K–$15K
0.1% of NW
14.3 ↗ filing
Gilbert Cisneros House SELL ◆ insider divergence · moderate Self · 150 Main Street Trust > Bank of America 2026-01-09 33 days +11.4% $1K–$15K
0.1% of NW
28.4 ↗ filing
Rohit Khanna House BUY OCR ◆ insider convergence · moderate Child 2025-12-05 30 days +2.3% $1K–$15K 20.0 ↗ filing
Gilbert Cisneros House BUY ◆ insider convergence · moderate Self · 150 Main Street Trust > Bank of America 2025-11-12 30 days +4.0% $1K–$15K
0.1% of NW
82.5 ↗ filing
Lisa McClain House SELL ◆ insider divergence · moderate Spouse · Charles Schwab 401K > Schwab 893 2025-10-31 1 days 0.0% $1K–$15K
0.1% of NW
17.7 ↗ filing
Lisa McClain House SELL ◆ insider divergence · moderate Spouse · Charles Schwab Brokerage Account 924 2025-10-30 2 days +0.9% $1K–$15K
0.1% of NW
33.4 ↗ filing
Lisa McClain House BUY ◆ insider convergence · moderate Spouse · Charles Schwab 401K > Schwab 893 2025-10-30 2 days +0.9% $1K–$15K
0.1% of NW
33.4 ↗ filing
Julia Letlow House SELL Self · Merrill Lynch Investment Account #025 2025-10-01 31 days -9.3% $1K–$15K
1.0% of NW
54.6 ↗ filing
Lisa McClain House BUY Spouse · Charles Schwab Brokerage Account 924 2025-09-25 6 days -2.0% $1K–$15K
0.1% of NW
64.0 ↗ filing
Valerie Hoyle House SELL Spouse · Fidelity Rollover IRA 2025-09-23 0 days 0.0% $1K–$15K
0.8% of NW
49.2 ↗ filing
Scott Franklin House SELL Joint · Fidelity Joint TBE 2025-06-16 1 days -1.0% $1K–$15K
0.1% of NW
27.5 ↗ filing
Valerie Hoyle House BUY Spouse · Fidelity Rollover IRA 2024-10-29 317 days -14.1% $1K–$15K
0.8% of NW
84.9 ↗ filing
Julia Letlow House BUY Self · Merrill Lynch Investment Account #025 2024-10-23 292 days -4.2% $1K–$15K
1.0% of NW
85.2 ↗ filing
Rohit Khanna House BUY OCR Child 2024-10-14 24 days +6.3% $1K–$15K 33.6 ↗ filing
Scott Franklin House SELL Self · Fidelity Traditional IRA 2024-08-06 10 days — $1K–$15K
0.1% of NW
63.3 ↗ filing
Rohit Khanna House BUY OCR Child 2024-05-29 6 days — $1K–$15K 22.3 ↗ filing
Rohit Khanna House BUY OCR Child 2024-03-25 9 days — $1K–$15K 40.4 ↗ filing
Rohit Khanna House BUY OCR Child 2023-12-05 30 days — $1K–$15K 75.9 ↗ filing
Lois Frankel House SELL ◆ insider divergence · moderate Self · Morgan Stanley IRA - X141 2023-09-08 28 days — $1K–$15K
0.3% of NW
15.7 ↗ filing
Lois Frankel House BUY ◆ insider convergence · moderate Self · Morgan Stanley IRA - X141 2023-08-10 15 days — $1K–$15K
0.3% of NW
22.3 ↗ filing
Lois Frankel House BUY ◆ insider convergence · moderate Self · Morgan Stanley IRA - X141 2023-08-03 22 days — $1K–$15K
0.3% of NW
40.4 ↗ filing
Lois Frankel House BUY ◆ insider convergence · moderate Self · Morgan Stanley IRA - X141 2023-08-02 23 days — $1K–$15K
0.3% of NW
75.9 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in KVUE — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

11
Congress trades with insider convergence
6
…with insider divergence
7
Insider open-market trades

Of the congressional trades in KVUE, 11 coincided with corporate insiders moving the same way within 60 days, and 6 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-06-10 Howlett Heather C-suite SELL $67K ↗ EDGAR
2026-05-08 Orlando Matthew Other SELL $680K ↗ EDGAR
2025-12-12 Smith Jeffrey C Director BUY $55.6M ↗ EDGAR
2025-12-11 Smith Jeffrey C Director BUY $55.4M ↗ EDGAR
2025-03-13 Lawson Carlton C-suite SELL $394K ↗ EDGAR
2023-08-30 ALLISON RICHARD E JR Director BUY $129K ↗ EDGAR
2023-05-11 ALLISON RICHARD E JR Director BUY $525K ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
Congress 2026-08-05 Kevin Hern SELL $1K–$15K
Congress 2026-07-17 Gilbert Cisneros SELL $1K–$15K
Congress 2026-06-16 Gilbert Cisneros BUY $1K–$15K
◆ insider 2026-06-10 Howlett Heather C-suite SELL $67K
◆ insider 2026-05-08 Orlando Matthew Other SELL $680K
Congress 2026-03-27 Alan Armstrong BUY $1K–$15K
Congress 2026-03-17 Kevin Hern SELL $15K–$50K
Congress 2026-03-13 Gilbert Cisneros SELL $1K–$15K
Congress 2026-02-10 Gilbert Cisneros BUY $1K–$15K
Congress 2026-01-09 Gilbert Cisneros SELL $1K–$15K
◆ insider 2025-12-12 Smith Jeffrey C Director BUY $55.6M
◆ insider 2025-12-11 Smith Jeffrey C Director BUY $55.4M
Congress 2025-12-05 Rohit Khanna BUY $1K–$15K
Congress 2025-11-12 Gilbert Cisneros BUY $1K–$15K
Congress 2025-10-31 Lisa McClain SELL $1K–$15K
Congress 2025-10-30 Lisa McClain SELL $1K–$15K
Congress 2025-10-30 Lisa McClain BUY $1K–$15K
Congress 2025-10-01 Julia Letlow SELL $1K–$15K
Congress 2025-09-25 Lisa McClain BUY $1K–$15K
Congress 2025-09-23 Valerie Hoyle SELL $1K–$15K
Congress 2025-06-16 Scott Franklin SELL $1K–$15K
◆ insider 2025-03-13 Lawson Carlton C-suite SELL $394K
Congress 2024-10-29 Valerie Hoyle BUY $1K–$15K
Congress 2024-10-23 Julia Letlow BUY $1K–$15K

FAQ Common questions

How much has Congress traded KVUE?

16 disclosed buys and 12 sells of KVUE (Kenvue Inc.) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade KVUE?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.